Literature DB >> 12409677

ESPAC-1 trial of adjuvant therapy for resectable adenocarcinoma of the pancreas.

Douglas B Evans, Kenneth R Hess, Peter W T Pisters.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12409677      PMCID： PMC1422632          DOI： 10.1097/01.SLA.0000037256.09376.FC

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  2 in total

1.  Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.

Authors:  J P Neoptolemos; J A Dunn; D D Stocken; J Almond; K Link; H Beger; C Bassi; M Falconi; P Pederzoli; C Dervenis; L Fernandez-Cruz; F Lacaine; A Pap; D Spooner; D J Kerr; H Friess; M W Büchler
Journal:  Lancet       Date:  2001-11-10       Impact factor: 79.321

2.  Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.

Authors:  J P Neoptolemos; D D Stocken; J A Dunn; J Almond; H G Beger; P Pederzoli; C Bassi; C Dervenis; L Fernandez-Cruz; F Lacaine; J Buckels; M Deakin; F A Adab; R Sutton; C Imrie; I Ihse; T Tihanyi; A Olah; S Pedrazzoli; D Spooner; D J Kerr; H Friess; M W Büchler
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969
  2 in total
  13 in total

Review 1.  Adjuvant and neoadjuvant systemic therapy for pancreas adenocarcinoma.

Authors:  Daneng Li; Eileen M O'Reilly
Journal:  Semin Oncol       Date:  2014-12-09       Impact factor: 4.929

Review 2.  Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal".

Authors:  Paula Ghaneh; Catrin Tudur-Smith; John P Neoptolemos
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Current status of adjuvant therapy for pancreatic cancer.

Authors:  Matthew H G Katz; Jason B Fleming; Jeffrey E Lee; Peter W T Pisters
Journal:  Oncologist       Date:  2010-11-02

4.  Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone.

Authors:  Andrew M McDonald; Caleb R Dulaney; Javier López-Araujo; James A Posey; Kimberly S Keene; John D Christein; Martin J Heslin; Tina E Wood; Rojymon Jacob
Journal:  J Gastrointest Cancer       Date:  2015-06

5.  Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.

Authors:  Matthew H G Katz; Nipun B Merchant; Steven Brower; Megan Branda; Mitchell C Posner; L William Traverso; Ross A Abrams; Vincent J Picozzi; Peter W T Pisters
Journal:  Ann Surg Oncol       Date:  2010-09-01       Impact factor: 5.344

6.  A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care.

Authors:  Susanna W L de Geus; Lindsay A Bliss; Mariam F Eskander; Sing Chau Ng; Alexander L Vahrmeijer; Anand Mahadevan; Tara S Kent; A James Moser; Mark P Callery; Bert A Bonsing; Jennifer F Tseng
Journal:  J Gastrointest Surg       Date:  2015-10-01       Impact factor: 3.452

Review 7.  Diagnosis and management of pancreatic cancer.

Authors:  A Collins; M Bloomston
Journal:  Minerva Gastroenterol Dietol       Date:  2009-12

8.  Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.

Authors:  Adam C Mueller; Miles Piper; Andrew Goodspeed; Shiv Bhuvane; Jason S Williams; Shilpa Bhatia; Andy V Phan; Benjamin Van Court; Kathryn L Zolman; Brisa Peña; Ayman J Oweida; Sara Zakem; Cheryl Meguid; Michael W Knitz; Laurel Darragh; Thomas E Bickett; Jacob Gadwa; Luisa Mestroni; Matthew R G Taylor; Kimberly R Jordan; Peter Dempsey; M Scott Lucia; Martin D McCarter; Marco Del Chiaro; Wells A Messersmith; Richard D Schulick; Karyn A Goodman; Michael J Gough; Casey S Greene; James C Costello; Antonio Galveo Neto; David Lagares; Kirk C Hansen; Adrie Van Bokhoven; Sana D Karam
Journal:  Cancer Res       Date:  2021-02-01       Impact factor: 12.701

9.  Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study.

Authors:  Charles C Hsu; Joseph M Herman; Michele M Corsini; Jordan M Winter; Matthew D Callister; Michael G Haddock; John L Cameron; Timothy M Pawlik; Richard D Schulick; Christopher L Wolfgang; Daniel A Laheru; Michael B Farnell; Michael J Swartz; Leonard L Gunderson; Robert C Miller
Journal:  Ann Surg Oncol       Date:  2010-01-20       Impact factor: 5.344

10.  Adjuvant radiation provides survival benefit for resected pancreatic adenocarcinomas of the tail.

Authors:  William H Jin; Sarah E Hoffe; Ravi Shridhar; Tobin Strom; Puja Venkat; Gregory M Springett; Pamela J Hodul; Jose M Pimiento; Kenneth L Meredith; Mokenge P Malafa; Jessica M Frakes
Journal:  J Gastrointest Oncol       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.